Vera Therapeutics (VERA) Leases (2022 - 2026)
Vera Therapeutics posted quarterly Leases of $1.8 million for Q1 2026, down 38.04% year-on-year from $2.9 million in Q1 2025, and down 6.08% on a QoQ basis from $1.9 million in Q4 2025.
Vera Therapeutics (VERA) has 5 years of Leases data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 38.04% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 38.04% YoY), and the FY2025 full-year result was $1.9 million, down 42.97% from the prior year.
- Leases for Q1 2026 stood at $1.8 million, down from $1.9 million in the prior quarter.
- Across five years, Leases topped out at $6.3 million in Q1 2022 and bottomed at $1.8 million in Q1 2026.
- The 5-year median for Leases is $3.4 million (2024), against an average of $3.6 million.
- The widest annual swing landed in 2024, when Leases slumped 52.13%; it then gained 28.1% in 2025.
- A 5-year view of Leases shows it stood at $5.2 million in 2022, then slumped by 42.99% to $2.9 million in 2023, then rose by 14.34% to $3.4 million in 2024, then slumped by 42.97% to $1.9 million in 2025, then fell by 6.08% to $1.8 million in 2026.
- The last three Leases figures came in at $1.8 million (Q1 2026), $1.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.47 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.95 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 5.17 Mn |
| Sep 30, 2022 | 5.77 Mn |
| Jun 30, 2022 | 5.72 Mn |
| Mar 31, 2022 | 6.28 Mn |